Quarterly report pursuant to Section 13 or 15(d)

Schedule of Stock Options Outstanding (Details)

v3.21.2
Schedule of Stock Options Outstanding (Details) - USD ($)
6 Months Ended
Jun. 11, 2020
Jun. 30, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Stock Option Outstanding, Granted 74,668,000  
Stock Options [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Stock Option Outstanding, Beginning Balance   3,014,080
Weighted Average Exercise Price, Beginning Balance   $ 0.37
Weighted Average Remaining Contractual Term (years), Outstanding Beginning   1 year 8 months 1 day
Aggregated Intrinsic Value, Outstanding Ending  
Stock Option Outstanding, Granted  
Weighted Average Exercise Price, Granted  
Weighted Average Remaining Contractual Term (years), Granted  
Aggregated Intrinsic Value, Outstanding, Granted  
Stock Option Outstanding, Cancelled   (350)
Weighted Average Exercise Price, Cancelled   $ 47.00
Weighted Average Remaining Contractual Term (years), Cancelled  
Aggregated Intrinsic Value, Outstanding, Cancelled  
Stock Option Outstanding, Exercised  
Weighted Average Exercise Price, Exercised  
Weighted Average Remaining Contractual Term (years), Exercised  
Aggregated Intrinsic Value, Outstanding, Exercised  
Stock Option Outstanding, Ending Balance   3,013,730
Weighted Average Exercise Price, Ending Balance   $ 0.37
Weighted Average Remaining Contractual Term (years), Outstanding Ending   2 years 6 months 18 days
Aggregated Intrinsic Value, Outstanding Ending  
Stock Option Outstanding, Exercisable Ending Balance   1,013,730
Weighted Average Exercise Price, Exercisable Ending Balance   $ 0.80
Weighted Average Remaining Contractual Term (years), Exercisable   1 year 6 months 29 days
Aggregated Intrinsic Value, Exercisable Ending